These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of S-warfarin administration on vitamin K 2,3-epoxide reductase activity in liver, kidney and testis of the rat. Thijssen HH; Janssen CA; Drittij-Reijnders MJ Biochem Pharmacol; 1986 Oct; 35(19):3277-82. PubMed ID: 3768021 [TBL] [Abstract][Full Text] [Related]
6. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase. Thijssen HH; Baars LG Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010 [TBL] [Abstract][Full Text] [Related]
7. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin. Thijssen HH Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase. Hazelett SE; Preusch PC Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202 [TBL] [Abstract][Full Text] [Related]
9. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes. Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443 [TBL] [Abstract][Full Text] [Related]
10. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats. Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923 [No Abstract] [Full Text] [Related]
11. Biochemical basis of warfarin and bromadiolone resistance in the house mouse, Mus musculus domesticus. Misenheimer TM; Lund M; Baker EM; Suttie JW Biochem Pharmacol; 1994 Feb; 47(4):673-8. PubMed ID: 8129744 [TBL] [Abstract][Full Text] [Related]
12. Warfarin resistance in a French strain of rats. Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894 [TBL] [Abstract][Full Text] [Related]
13. Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation. Trivedi LS; Rhee M; Galivan JH; Fasco MJ Arch Biochem Biophys; 1988 Jul; 264(1):67-73. PubMed ID: 3395132 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver. Hildebrandt EF; Suttie JW Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339 [TBL] [Abstract][Full Text] [Related]
15. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance. Preusch PC; Suttie JW J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460 [TBL] [Abstract][Full Text] [Related]
16. Vitamin K reductases in normal and in warfarin-resistant rats. Vermeer C; Soute BA; Aalten M; Knapen MH; Thijssen HH Biochem Pharmacol; 1988 Jul; 37(14):2876-8. PubMed ID: 3134893 [No Abstract] [Full Text] [Related]
17. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats. Hallak HO; Wedlund PJ Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414 [No Abstract] [Full Text] [Related]
18. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat. Mosterd JJ; Thijssen HH J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379 [TBL] [Abstract][Full Text] [Related]
19. Warfarin resistance in a Chicago strain of rats. Misenheimer TM; Suttie JW Biochem Pharmacol; 1990 Nov; 40(9):2079-84. PubMed ID: 2242035 [TBL] [Abstract][Full Text] [Related]
20. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity. Thijssen HH; Baars LG; Vervoort-Peters HT Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]